LAIR2 Human

Leukocyte-Associated Ig-Like Receptor 2 Human Recombinant
Cat. No.
BT2753
Source
Escherichia Coli.
Synonyms
Leukocyte-associated immunoglobulin-like receptor 2, LAIR-2, CD306, LAIR2.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

LAIR2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 139 amino acids (22-135 a.a) and having a molecular mass of 15.2kDa.
LAIR2 is fused to a 25 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
Leukocyte-associated immunoglobulin-like receptor 2 (LAIR2) is a secreted protein composed of 131 amino acids. Classified as a member of the Ig superfamily due to its single Ig-like C2 type domain, LAIR2 is believed to have a common gene ancestor with LAIR1, an inhibitory receptor found on mononuclear leukocytes. Despite their shared evolutionary history and potential for similar adhesion profiles, LAIR2 is secreted while LAIR1 remains membrane-bound. This suggests a possible competitive relationship for ligand binding between the two. Discovered through its resemblance to LAIR1, LAIR2's gene is located within the leukocyte receptor cluster at 19q13.4, a region home to 29 immunoglobulin superfamily genes, including LAIR1. Although the precise function of LAIR2 remains unclear, its secreted nature suggests a potential role in modulating mucosal tolerance.
Description
Recombinant human LAIR2, produced in E. coli, is a non-glycosylated polypeptide chain consisting of 139 amino acids (specifically, amino acids 22-135). This protein has a molecular weight of 15.2 kDa and features a 25 amino acid His-tag at its N-terminus. Purification is achieved using proprietary chromatographic techniques.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The LAIR2 protein solution is provided at a concentration of 1 mg/ml and is formulated in a buffer containing 20 mM Tris-HCl (pH 8.0), 20% glycerol, 0.1 M NaCl, and 1 mM DTT.
Stability
For short-term storage (up to 4 weeks), the LAIR2 protein solution should be kept at 4°C. For long-term storage, it is recommended to freeze the solution at -20°C. To ensure optimal stability during long-term storage, adding a carrier protein such as HSA or BSA (0.1%) is advised. Repeated freezing and thawing of the solution should be avoided.
Purity
The purity of LAIR2 is determined by SDS-PAGE analysis and is consistently greater than 90%.
Synonyms
Leukocyte-associated immunoglobulin-like receptor 2, LAIR-2, CD306, LAIR2.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMQEGAL PRPSISAEPG TVISPGSHVT FMCRGPVGVQ TFRLEREDRA KYKDSYNVFR LGPSESEARF HIDSVSEGNA GLYRCLYYKP PGWSEHSDFL ELLVKGTVPG TEASGFDAP.

Product Science Overview

Structure and Expression

LAIR-2 is a soluble receptor that shares 84% sequence homology with LAIR-1, another member of the LAIR family . Unlike LAIR-1, which is a membrane-bound receptor, LAIR-2 lacks a transmembrane and cytoplasmic region, indicating that it is secreted . The protein has a single immunoglobulin (Ig)-like domain and is expressed in various tissues, including peripheral blood mononuclear cells (PBMCs) .

Function

LAIR-2 functions as a natural competitor to LAIR-1 by binding to collagen molecules with high affinity . This binding is hydroxyproline-dependent, and LAIR-2 can inhibit the interaction between LAIR-1 and collagen . By doing so, LAIR-2 regulates the inhibitory potential of LAIR-1, which is known to inhibit immune cell function upon collagen binding . This regulatory mechanism is crucial for maintaining immune homeostasis and preventing excessive immune reactions or autoimmune diseases .

Clinical Significance

The expression of LAIR-2 has been observed in various clinical conditions. For instance, high levels of LAIR-2 have been detected in the urine of pregnant women and in the synovial fluid of patients with rheumatoid arthritis . These findings suggest that LAIR-2 may play a role in immune regulation during pregnancy and in inflammatory diseases .

Research and Applications

Research on LAIR-2 has provided insights into its potential therapeutic applications. By understanding the mechanisms through which LAIR-2 regulates immune responses, scientists can develop strategies to modulate its activity for therapeutic purposes. For example, targeting LAIR-2 could be beneficial in treating autoimmune diseases or in enhancing immune responses against infections and tumors .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.